CD

Avid Bioservices IncNASDAQ CDMO Stock Report

Last reporting period 31 Jul, 2024

Updated 15 Nov, 2024

Last price

Market cap $B

0.741

Micro

Exchange

XNAS - Nasdaq

CDMO Stock Analysis

CD

Uncovered

Avid Bioservices Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-54/100

Low score

Market cap $B

0.741

Dividend yield

Shares outstanding

62.547 B

Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing, focused on biopharmaceutical drug substances derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The Company also provides a variety of process development services, including upstream and downstream development and optimization, analytical methods development, testing and characterization.

View Section: Eyestock Rating